Bioceramic Therapeutics - Imperial College London - Synthetic components for orthopaedic regenerative medicine
Marc de Garidel, Vice President, Amgen International, right, presented the Amgen Life Sciences Award to Stephan Rietiker, Chairman, BioCeramic Therapeutics, who represented Molly Stevens.
Professor Molly Stevens from Imperial College London won the Amgen Life Sciences award on the basis of her role in the founding and running of Bioceramic Therapeutics Ltd. Her company has developed a novel scaffold for regrowing bone, cartilage and other tissue. With the prize comes a cheque from Amgen for €5000. The judges praised the transformation of outstanding science into an innovative company with enormous potential for human health.
Prize: €5000
